🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 2 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/08/2025 11,90 11,96 11,60 11,64 -2,35% 3,03% 3.331.900
22/08/2025 11,85 12,03 11,82 11,92 +0,93% 1,73% 4.902.300
21/08/2025 11,59 11,82 11,54 11,81 +0,77% 2,42% 3.282.300
20/08/2025 11,76 11,80 11,64 11,72 -0,34% 1,40% 3.218.000
19/08/2025 11,75 11,85 11,68 11,76 -0,42% 1,45% 3.452.700
18/08/2025 11,83 11,97 11,75 11,81 -0,34% 1,82% 3.930.600
15/08/2025 11,75 11,91 11,68 11,85 +0,85% 1,97% 3.837.400
14/08/2025 11,88 12,12 11,72 11,75 -1,76% 3,37% 5.582.800
13/08/2025 11,60 11,98 11,57 11,96 +3,37% 3,49% 6.863.900
12/08/2025 11,30 11,69 11,24 11,57 +3,58% 3,98% 8.346.400
11/08/2025 10,90 11,43 10,90 11,17 -2,79% 4,82% 7.318.000
08/08/2025 11,53 11,58 11,40 11,49 -0,52% 1,56% 3.416.800
07/08/2025 11,65 11,72 11,41 11,55 -0,86% 2,66% 4.643.200
06/08/2025 11,55 11,67 11,36 11,65 +0,17% 2,68% 4.080.100
05/08/2025 11,50 11,67 11,41 11,63 +1,04% 2,22% 5.547.700
04/08/2025 11,35 11,52 11,23 11,51 +1,77% 2,60% 3.109.800
01/08/2025 11,30 11,36 11,12 11,31 -0,44% 2,12% 2.910.700
31/07/2025 11,30 11,51 11,26 11,36 -0,35% 2,17% 3.547.900
30/07/2025 11,44 11,63 11,36 11,40 -0,18% 2,36% 3.400.300
29/07/2025 11,39 11,47 11,32 11,42 +0,62% 1,32% 3.806.100
28/07/2025 11,55 11,60 11,31 11,35 -1,73% 2,51% 3.565.100
25/07/2025 11,58 11,65 11,35 11,55 +1,49% 2,55% 4.358.200
24/07/2025 11,34 11,60 11,31 11,38 -0,09% 2,56% 5.224.400
23/07/2025 11,58 11,64 11,37 11,39 -0,96% 2,33% 3.360.800
22/07/2025 11,52 11,60 11,45 11,50 +0,17% 1,30% 3.829.900
21/07/2025 11,48 11,62 11,45 11,48 +0,35% 1,48% 5.180.000
18/07/2025 11,70 11,74 11,38 11,44 -1,80% 3,07% 4.930.000
17/07/2025 11,50 11,68 11,49 11,65 +0,95% 1,65% 4.463.400
16/07/2025 11,43 11,62 11,43 11,54 +1,58% 1,66% 4.783.500
15/07/2025 11,69 11,78 11,31 11,36 -2,32% 4,02% 4.782.200